Wegovy 2.4 mg solution for injection Summary of Product Characteristics
If hitting your protein target is difficult due to reduced appetite, protein shakes can fill the gap
Dosing above 120mg/day shows no additional enzyme inhibition benefit but significantly increases peptide consumption cost
It is also approved for chronic weight management in adults who are obese (BMI 30) or overweight (BMI 27) and have at least one weight-related comorbid condition, such as hypertension or dyslipidemia
In this study, acute administration of the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide to mice increased the cecal levels of caseinolytic protease B, a component of Escherichia coli , and of norepinephrine
Initial research is highly concerning that these medications have side effects that need further research before widespread drug administration and adoption, significantly decrease muscle mass, and can cause significant weight gain after stopping